Go to deals
Healthcare

Sedona Invest has acquired Abiocom

The shareholders of Abiocom have sold the company to Sedona Invest.

Sedona Invest is a family office founded in 2020 dedicated to the well-being and organic industries.

Founded in 2007, Abiocom is specialized in design, development and distribution of organic well-being products. The company provides a wide range of more than 300 products from seven own brands and two other brands in exclusive distribution, covering five categories: food supplements, cosmetics, make-up, incense and eco-housing. Abiocom has a portfolio of over 1,700 active clients, including organic chains and independent stores.

Oaklins’ team in France acted as advisor to the shareholders of Sedona Invest in this transaction.

Parties

Talk to the deal team

Ludovic Beaulieu

Partner
Paris, France
Oaklins France

Antoine Lemaire

Partner
Paris, France
Oaklins France

Quentin Boissinot

Associate
Paris, France
Oaklins France

Related deals

Leika Medical Equipments Ltd. has been acquired by Angus Capital
Private Equity | Healthcare

Leika Medical Equipments Ltd. has been acquired by Angus Capital

The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.

Learn more
Phen’X Technologies has sold a majority stake to Ciclad
Private Equity | Healthcare | Industrial Machinery & Components

Phen’X Technologies has sold a majority stake to Ciclad

The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.

Learn more
Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments
Healthcare | TMT

Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments

Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).

Learn more